Poseida Therapeutics, Inc. (PSTX) Financials
Stock symbol PSTX is outdated, potentially delisted? Maybe it is available on other exchange?
PSTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 293.6 million | 206.4 million |
| June 30, 2024 | 298.7 million | 237.9 million |
| March 31, 2024 | 262.6 million | 178.0 million |
| Dec. 31, 2023 | 273.9 million | 170.2 million |
PSTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | -10.2 million | 5.0 million |
| June 30, 2024 | 37.4 million | 7.6 million |
| March 31, 2024 | -15.3 million | 5.4 million |
| Dec. 31, 2023 | -29.1 million | 5.1 million |
PSTX Net Income
No data available :(
PSTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 230.9 million | 76.6 million | - |
| June 30, 2024 | 237.8 million | 77.6 million | 24.9 million |
| March 31, 2024 | 198.6 million | 78.6 million | 25.9 million |
| Dec. 31, 2023 | 212.2 million | 79.5 million | 26.8 million |
PSTX Shares Outstanding
PSTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | 645001 | 41.9 million | 10.1 million | - |
| June 30, 2024 | 1.0 million | 44.2 million | 12.2 million | - |
| March 31, 2024 | 130000 | 41.5 million | 9.8 million | - |
| Dec. 31, 2023 | 309000 | 42.0 million | 8.9 million | - |
PSTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | 71.7 million | - |
| June 30, 2024 | 26.0 million | 1.3 million |
| March 31, 2024 | 28.1 million | 1.4 million |
| Dec. 31, 2023 | 25.0 million | 4.2 million |
PSTX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
PSTX
Price: $9.50
52 week price:
Earnings Per Share: -0.63 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 268000
Market Capitalization: 927.9 million